News

06 Apr 2017

Derek Mackay, SNP Cabinet Secretary for Finance and the Constitution, visits REPROCELL Europe, Glasgow

Derek Mackay, SNP Cabinet Secretary for Finance and the Constitution, visits REPROCELL Europe, Glasgow
Read More >>

03 Mar 2017

ReproCELL Europe's CEO Dr David Bunton presented at NC3Rs workshop: Human tissue models for cancer research

ReproCELL Europe's CEO, Dr David Bunton presented at the recent NC3Rs meeting on the use of human tissues in cancer research. The conference considered the potential for human tissue models to help reduce clinical drug attrition and provide more relevant models of cancer using techniques such as 3D models, PDX systems and precision-cut tumour slices.
Read More >>

14 Feb 2017

ReproCELL Inc CEO meets with Scottish Cabinet Secretary Fiona Hyslop in Japan

ReproCELL Inc. (Japan)s CEO Dr Chikafumi Yokoyama had the honour of meeting with Fiona Hyslop, Cabinet Secretary for Culture, Tourism and External Affairs for the Scottish Government, during her visit to the Scottish Enterprise Tokyo office, today (14 February 2017).
Read More >>

07 Feb 2017

Scottish Enterprise Association Honours ReproCELL with Annual Awards Nomination

Scottish Enterprise Association Honours ReproCELL with Annual Awards Nomination
Read More >>

1 2 3 4 >>

Joint enterprise - Development of Drug Discovery Applications Using Neurons Derived from iPS Cells

14/11/2016

Joint Enterprise of Keio University and Juntendo University - Notice regarding inclusion in Relevant Leading Businesses to Receive Assistance in the Special District of Yokohama City for the project of “Development of Drug Discovery Applications Using Neurons Derived from iPS Cells”

Herein is notice that the joint enterprise “Development of Drug Discovery Applications Using Neurons Derived from iPS Cells” by Keio University and Juntendo University (hereinafter “this joint enterprise”) pertaining to the Keihin coastal area Life Innovation International Strategy Comprehensive Special Zone “Yokohama Project” has been chosen as a business proposal to receive financial assistance for Relevant Leading Businesses in the Special District of Yokohama City in 2016.

The purpose of the “Assistance for Leading Businesses in the Special District” is the creation of health-related industries and the development or production of innovative drugs and medical devices by global businesses within the field of personalized/preventative medicine. The assistance is given to businesses in special districts that contribute to revitalizing the economy of Yokohama by expanding employment and industrial clusters in the city, and for worthy academic – industrial collaborations.

 

The purpose of this joint enterprise is to create new drug development technologies using neurons derived from iPS cells originating from patients, and to generate supporting applications. It is intended that such technologies could independently be adopted by the Pharmaceutical industry, or employed through collaborations with ReproCELL, Keio University, and/or Juntendo University. Furthermore, such technologies are expected to lower costs and shorten the period of time for developing and delivering innovative new therapies to patients in need.

 

Financial support to ReproCELL will be received to support research and development related to this joint enterprise. However, grant funds are expected to be delivered in the following year and therefore will not affect the earnings outlook for the current year.

 

ReproCELL will strategically pursue this and other research projects that utilize patient-derived IPS cells to develop tools and therapies related to regenerative medicine.

 

Details of the relevant terms related to the project “Assistance for Leading Businesses in the Special District of Yokohama City for 2016”

 

Name of project: “Development of Drug Discovery Applications Using Neurons Derived from iPS Cells”

 

Assistance period: October 2016 ~ March 2017

 

Estimated assistance amount: About 23,998,000 JPY (our company will initially receive the entire lump sum, and then distribute portions to Keio University and Juntendo University)

 

End.

Live chat by BoldChat